Actinium Pharmaceuticals, Inc. (ATNM)

USD 1.16

(-4.92%)

Revenue Summary of Actinium Pharmaceuticals, Inc.

  • Actinium Pharmaceuticals, Inc.'s latest annual revenue in 2023 was 81 Thousand USD , down -92.14% from previous year.
  • Actinium Pharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Actinium Pharmaceuticals, Inc. reported a annual revenue of 1.03 Million USD in annual revenue 2022, down -9.97% from previous year.
  • Actinium Pharmaceuticals, Inc. reported a annual revenue of 1.14 Million USD in annual revenue 2021, down 0.0% from previous year.
  • Actinium Pharmaceuticals, Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • Actinium Pharmaceuticals, Inc. reported a quarterly revenue of 81 Thousand USD for 2023 FY, down -92.14% from previous quarter.

Annual Revenue Chart of Actinium Pharmaceuticals, Inc. (2023 - 2006)

Historical Annual Revenue of Actinium Pharmaceuticals, Inc. (2023 - 2006)

Year Revenue Revenue Growth
2023 81 Thousand USD -92.14%
2022 1.03 Million USD -9.97%
2021 1.14 Million USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Revenue Comparison of Actinium Pharmaceuticals, Inc.

Name Revenue Revenue Difference
AIM ImmunoTech Inc. 202 Thousand USD 59.901%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Armata Pharmaceuticals, Inc. 4.52 Million USD 98.212%
Azitra, Inc. 686 Thousand USD 88.192%
Can-Fite BioPharma Ltd. 743 Thousand USD 89.098%
Chromocell Therapeutics Corporation - USD -Infinity%
Calidi Biotherapeutics, Inc. - USD -Infinity%
CEL-SCI Corporation - USD -Infinity%
iBio, Inc. 225 Thousand USD 64.0%
Lineage Cell Therapeutics, Inc. 8.94 Million USD 99.094%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 1.09 Million USD 92.609%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -23.378%
NovaBay Pharmaceuticals, Inc. 14.72 Million USD 99.45%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. 37.65 Thousand USD -115.122%
BiomX Inc. -357 Thousand USD 122.689%
BiomX Inc. -357 Thousand USD 122.689%
Protalix BioTherapeutics, Inc. 65.49 Million USD 99.876%
Palatin Technologies, Inc. 4.49 Million USD 98.196%
Scorpius Holdings, Inc. 6.99 Million USD 98.842%